Identification of selective dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) inhibitors and their effects on tau and microtubule-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Identification of selective dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) inhibitors and their effects on tau and microtubule

Published:2024-02 Issue: Volume:259 Page:129074
ISSN:0141-8130
Container-title:International Journal of Biological Macromolecules
language:en
Short-container-title:International Journal of Biological Macromolecules

Author:

Wu Yi-Wen,HuangFu Wei-Chun,Lin Tony Eight,Peng Chao-Hsiang,Tu Huang-Ju,Sung Ting-Yi,Sung Tzu-Ying,Yen Shih-Chung,Pan Shiow-Lin,Hsu Kai-Cheng

Funder

Ministry of Science and Technology

Academia Sinica

Publisher

Elsevier BV

Subject

Molecular Biology,General Medicine,Biochemistry,Structural Biology

Reference48 articles.

1. MNB/DYRK1A as a multiple regulator of neuronal development;Tejedor;FEBS J.,2011

2. Selective DYRK1A inhibitor for the treatment of neurodegenerative diseases: Alzheimer, Parkinson, Huntington, and down syndrome;Kargbo;ACS Med. Chem. Lett.,2020

3. The role of DYRK1A in neurodegenerative diseases;Wegiel;FEBS J.,2011

4. DYRK1A BAC transgenic mice show altered synaptic plasticity with learning and memory defects;Ahn;Neurobiol. Dis.,2006

5. DYRK1A antagonists rescue degeneration and behavioural deficits of in vivo models based on amyloid-beta, tau and DYRK1A neurotoxicity;Zhu;Sci. Rep.,2022

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advances in Alzheimer’s disease: mechanisms, clinical trials and new drug development strategies;Signal Transduction and Targeted Therapy;2024-08-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP